Stealthy Swiss device maker Symetis announced today that it’s launching commercial sales of its Acurate neo transfemoral transcatheter aortic valve implantation system, having just won CE Mark approval from European regulators.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Medtronic wins FDA nod for NC Euphora balloon catheter
Harpoon Medical raises $3.8M for mitral valve device
Harpoon Medical is looking to move from concept to the clinic with the $3.8 million it raised in its Series A funding round in support of its mitral repair devices.
TAVI: Medtronic launches U.S. trial for CoreValve Evolut R
Tryton Medical raises $20M for side-branch stent trial
Tryton Medical said today that’s made an initial closing on a $20 million private equity round from existing and new investors.
TAVI: Claret Medical closes enrollment in brain defense study
Updated Sept. 5, 2014, at 11:00 a.m. EST.
Claret Medical announced this week that it enrolled the final patient in a European clinical trial as it chases FDA approval for its Sentinel cerebral protection device.*
St. Jude cries victory with its quadripolar leads
Medical device giant St. Jude Medical (NYSE:STJ) had high praise for its own quadripolar leads, saying that blow away any competition from older bipolar leads.
Boston Scientific’s WallFlex fares well in biliary stenting study
Medtech titan Boston Scientific (NYSE:BSX) unveiled new results from its WallFlex Biliary RX Stent study, touting perfect success in removing the device up to a year following implant.
Novation gets into heart valves with Edwards Lifesciences
Medtronic wins CE Mark for CoreValve Evolut R
Pacemakers learn from wristwatches to ditch batteries
Swiss researchers are taking a page from their country’s most iconic products to change how pacemakers are powered inside the body.